Document is current

Article History

Received: 14 May 2024

Accepted: 11 December 2024

First Online: 26 December 2024

Declarations

:

: J.C., G.S. and B.F. are employees of Haleon plc, the manufacturers of the Pronamel and Aquafresh products tested in this work. The studies included in this manuscript were sponsored and funded by Haleon plc, formerly GlaxoSmithKline Consumer Healthcare. A.H. and D.Z. are faculty at the Indiana University School of Dentistry, Oral Health Research Institute, which has received funding from Haleon/GlaxoSmithKline Consumer Healthcare. A.H. and D.Z. have received compensation from Haleon/GSK Consumer Healthcare as consultants in the past.

: J.C., G.S. and B.F. are employees of Haleon plc, the manufacturers of the Pronamel and Aquafresh products that were tested in this work. The studies included in this manuscript were sponsored and funded by Haleon plc, formerly GlaxoSmithKline Consumer Healthcare. A.H. and D.Z. are faculty at the Indiana University School of Dentistry, Oral Health Research Institute, which has received funding from Haleon/GlaxoSmithKline Consumer Healthcare. A.H. and D.Z. have received compensation from Haleon/GSK Consumer Healthcare as consultants in the past.

: All studies except one were performed at the Oral Health Research Institute at the Indiana University School of Dentistry. These studies obtained ethical approval from the Indiana University Institutional Review Board. The remaining study (code name RH02535, see Table 1) was performed at Intertek Clinical Research Services Ltd, Ellesmere Port, UK. This study obtained ethical approval from the North West-Liverpool Central Research Ethics Committee.

: All participants in all studies included in this meta-analysis freely gave written informed consent to take part in the study/studies in which they participated. Consent for publication is not applicable.